Breast Cancer | Specialty

The Longstanding Quest for a Better Endocrine Therapy Continues High-Dose Fulvestrant: Have We Found Its Effective Dose, Combination, Setting, or Sequence?

March 15th 2011

Although several endocrine therapies are available today, the authors of this commentary contend that the quest for a better tamoxifen is ongoing.

Exercise, Weight-Lifting Help in Preventing Lymphedema

March 15th 2011

Two studies presented at SABCS refined knowledge about how to prevent lymphedema in patients with breast cancer.

Dr. Tripathy on Bone Health in Breast Cancer Patients

March 15th 2011

Debu Tripathy, MD, Co-leader Women's Breast Cancer Program at USC/Norris Comprehensive Cancer Center, on bone health considerations for patients with breast cancer.

Dr. Tripathy Discusses Bisphosphonate Studies

March 15th 2011

Debu Tripathy, MD, Co-leader Women’s Breast Cancer Program at USC/Norris Comprehensive Cancer Center, discusses clinical research and studies looking at the use of bisphosphonate for women with breast cancer.

Dr. Pearlstone on Biomarker Testing in the Community

March 14th 2011

David Pearlstone, MD, Co-Division Chief, Breast Oncology from John Theurer Cancer Center on Biomarker Testing in the Community Setting

Dr. Pearlstone on Breast Cancer's 10 Year Progression

March 11th 2011

David Pearlstone, M.D. Co-Division Chief, Breast Oncology from John Theurer Cancer Center on Breast Cancer's Surgical Progression in the Past 10 Years

Dr. Osman on Detecting Malignant Breast Cancer

March 10th 2011

Daniel A. Osman, MD, Founder and Course Director of the Miami Breast Cancer Conference Discusses Methods for Detecting Malignant Conditions in Breast Cancer

Dr. Pearlstone on Struggles Facing Breast Oncologists

March 10th 2011

David Pearlstone, MD, Co-Division Chief, Breast Oncology from John Theurer Cancer Center on Struggles Facing Breast Oncologists

Dr. Pearlstone on Genomics and Personalized Medicine

March 10th 2011

David Pearlstone, M.D. Co-Division Chief, Breast Oncology from John Theurer Cancer Center on Genomics and Personalized Medicine

Dr. Pearlstone on his Role in Designing new Equipment

March 10th 2011

David Pearlstone, M.D. Co-Division Chief, Breast Oncology from John Theurer Cancer Center on his Role in Designing new Equipment

Diet and Lifestyle Are Factors in Breast Pain

March 10th 2011

Breast pain is among the most common reasons that women seek medical attention from a breast specialist.

Dr. Pearlstone on Current Biomarker Utilization

March 10th 2011

Dr. Pearlstone on Difficult Patient Conversations

March 10th 2011

Dr. Osman on Breast Cancer Changes in the Past 10 Years

March 10th 2011

Brufsky Urges Caution in Translating Assays

March 10th 2011

Amid advances in gene-based cancer diagnostics, questions about the best use of molecular and cellular assays in practice are growing along with the new options for clinicians.

Do Breast Implants Increase Cancer Risk?

March 10th 2011

The FDA is examining a potential link between breast implants and anaplastic large cell lymphoma (ALCL), a rare and aggressive form of non-Hodgkin lymphoma.

Breast Cancer Survivor Noreen Fraser Turns Anger into Action

March 10th 2011

Noreen Fraser clearly recalls the day in 2003 when her doctor informed her that the breast cancer she had been diagnosed with 2 years earlier had metastasized to her bones

NCCN Launches Consumer-Friendly Versions

March 9th 2011

NCCN Launches Consumer-Friendly Versions of Guideline Publications Breast cancer and non-small cell lung cancer are the inaugural entries in a new series of publications the National Comprehensive Cancer Network (NCCN) is rolling out in the coming months.

FDA Requests Label Change for Generic Docetaxel

March 9th 2011

The FDA has requested that the generic drug manufacturer Hospira change the planned label for its generic formulation of docetaxel.

Dr. Pearlstone on Practice Changing Studies

March 8th 2011